VentriFlo, Inc., a Pelham, N.H.-based developer of a a blood pumping platform, closed a $10m Series A funding.
The round was led by Jim and Pat Poitras and other investors.
The company intends to use the funds to continue the development and FDA 510(k) submission for its patented platform.
Led by Doug Vincent, President & CEO, VentriFlo is advancing tre VentriFlo® True Pulse Pump™, which is capable of replicating the native heartbeat by delivering blood flow with a life-like pulse during surgery or in the ICU.
VentriFlo True Pulse Pumps are under development, for investigational use only, and are not available for commercial sale.
The company was originated from Design Mentor, Inc., a NH corporation with a history of medical device design and development, specializing in fluid pumping.
FinSMEs
20/09/2019